Decision to secure supply of clomipramine hydrochloride and mirtazapine tablets
22 July 2021
What we’re doing
mirtazapine and
clomipramine hydrochloride tablets following the announcement that Apotex New Zealand Limited (Apotex), the current supplier, is leaving the New Zealand market.
This decision means that:
Mirtazapine 30 mg and 45 mg tablets
A new brand of 30 mg and 45 mg mirtazapine tablets will be funded from 1 August 2021. This will be the Noumed brand, supplied by Noumed Pharmaceuticals Limited (Noumed).
The Apo-Mirtazapine brand of mirtazapine (supplied by Apotex) will continue to be funded until 1 January 2022.
From 1 January 2022, the Noumed brand of 30 mg and 45 mg mirtazapine tablets will be the only funded brand of 30 mg and 45 mg mirtazapine tablets until 30 June 2024.